Claims for Patent: 6,784,254

Summary for Patent: 6,784,254

Title:	Process for removing bile salts from a patient and alkylated compositions therefor
Abstract:	The invention relates to a method for removing bile salts from a patient in need thereof and compositions useful in the method. The method comprises administering to the patient a therapeutically effective amount of a salt of an alkylated and crosslinked polymer. The alkylated and crosslinked polymer salt comprises the reaction product of crosslinked polymers, or salts and copolymers thereof having amine containing repeat units, with at least one aliphatic alkylating agent.
Inventor(s):	Mandeville, III; W. Harry (Lynnfield, MA), Holmes-Farley; Stephen Randall (Arlington, MA)
Assignee:	Genzyme Corporation (Cambridge, MA)
Application Number:	10/264,350
Patent Claims:	1. A composition comprising an alkylated and crosslinked polymer and salts thereof comprising the reaction product of: (a) one or more polymers, or salts and copolymers thereof having a repeat unit with the formula: ##STR3## where n is a positive integer and each R, independently, is H or a C.sub.1 -C.sub.8 alkyl group; (b) at least one aliphatic alkylating agent; and (c) a crosslinking agent, wherein said reaction product has: (i) at least some of the nitrogen atoms in said repeat units unreacted with said alkylating agent; and (ii) less than 10 mol % of the nitrogen atoms in said repeat units that react with said alkylating agent form quaternary ammonium units. 2. The composition of claim 1 wherein the salt has at least one counterion selected from the group consisting of: Cl.sup.-, Br.sup.-, CHOSO.sub.3.sup.-, HSO.sub.4.sup.-, SO.sub.4.sup.2-, HCO.sub.3.sup.-, CO.sub.3.sup.2-. 3. The composition of claim 1 wherein said polymer is crosslinked by means of a multifunctional crosslinking agent, said agent being present in an amount from about 0.5-25% by weight, based upon the combined weight of monomer and crosslinking agent. 4. The composition of claim 1 wherein the crosslinking agent comprises epichlorohydrin. 5. The composition of claim 1 wherein said alkylating agent has the formula RX where R is a C.sub.1 -C.sub.20 alkyl, C.sub.1 -C.sub.20 hydroxyalkyl, C.sub.1 -C.sub.20 alkylammonium, or C.sub.1 -C.sub.20 alkylamido group and X is one or more electrophilic leaving groups. 6. The composition of claim 5 wherein said alkylating agent comprises a C.sub.1 -C.sub.20 alkyl halide. 7. The composition of claim 5 wherein said alkylating agent comprises a C.sub.1 -C.sub.20 alkyl halide ammonium salt. 8. The composition of claim 7 wherein said alkyl halide ammonium salt is a C.sub.4 -C.sub.12 haloalkyl trimethylammonium salt. 9. The composition of claim 1 wherein said polymer is reacted with at least two of said alkylating agent, one of said alkylating agents has the formula RX where R is a C.sub.1 -C.sub.20 alkyl group and X is one or more electrophilic leaving groups, and the other of said alkylating agents has the formula R'X where R' is a C.sub.1 -C.sub.20 alkyl ammonium group and X is one or more electrophilic leaving groups. 10. The composition of claim 9 wherein one of said alkylating agents having the formula RX is an alkyl halide and the other of said alkylating agents having the formula R'X is an alkyl halide ammonium salt. 11. The composition of claim 10 wherein said alkyl halide is a C.sub.4 -C.sub.20 alkyl halide and said alkyl halide ammonium salt is a C.sub.4 -C.sub.18 alkyl halide ammonium salt. 12. The composition of claim 11 wherein said alkyl halide is a C.sub.10 alkyl halide and said alkyl halide ammonium salt is a C.sub.6 alkyl halide trimethyl ammonium salt. 13. The composition of claim 1, further comprising a pharmaceutically acceptable carrier.